John A Tine

Title: The Innovative Contributions of John A. Tine

Introduction

John A. Tine is a notable inventor based in Scotia, NY, who has made significant contributions to the field of immunology. With a total of three patents to his name, Tine's work focuses on the development of immunogenic polypeptides that have the potential to advance cancer treatment and immune response mechanisms.

Latest Patents

Among his latest patents, Tine has developed immunogenic polypeptides encoded by MAGE minigenes. This invention discloses immunogenic polypeptides that comprise several MAGE-specific antigen epitopes selected from different members of the MAGE protein family. The patents also include nucleic acids coding for these polypeptides, recombinant viruses, and cells that incorporate said nucleic acids. Furthermore, the methods for eliciting or inducing MAGE-specific immune responses utilizing these immunogenic agents are also disclosed.

Career Highlights

Throughout his career, John A. Tine has worked with prominent organizations such as Sanofi Pasteur Inc. and the Ludwig Institute for Cancer Research Limited. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects that aim to enhance therapeutic strategies in immunology.

Collaborations

Tine has collaborated with esteemed colleagues, including James Tartaglia and Philippe Moingeon. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

John A. Tine's innovative work in the field of immunology, particularly through his patents on MAGE minigenes, showcases his commitment to advancing medical science. His collaborations and career experiences further highlight his significant contributions to the field.